These trials completed more than 12 months ago and should have reported results. Some have, some have not.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Ongoing||2006-006166-42||Exelon bei dementiellem Syndrom bei Patienten mit Progressiver Supranukleärer Parese - offene, prospektive Phase II-Studie -||not-yet-due|
|Ongoing||2007-000410-37||Determination of glomerular filtration rate (GFR) using MR nephrography in patients with chronic kidney disease.||not-yet-due|
|Not reported||2009-009998-10||Myfortic (enteric-coated mycophenolate sodium) for the treatment of non-infectous intermediate uveitis – a prospective, controlled randomized multicenter trial||2015-10-12||due-trials|
|Ongoing||2012-000620-17||High-dose chemotherapy and autologous stem cell transplant or consolidating conventional chemotherapy in primary CNS lymphoma - randomized phase III trial||not-yet-due|
|Ongoing||2016-001611-20||Pathophysiology-based therapy of epileptic encephalopathies||not-yet-due|
|Ongoing||2016-003168-37||Therapeutic Iloprost for the treatment of Acute Respiratory Distress Syndrome (ARDS) (the ThIlo-Trial): a prospective, randomized, multicenter phase II study||not-yet-due|